tiprankstipranks
Advertisement
Advertisement
Jenscare Wins FDA Green Light for Pivotal U.S. Trial of LuX-Valve Plus
PremiumCompany AnnouncementsJenscare Wins FDA Green Light for Pivotal U.S. Trial of LuX-Valve Plus
2M ago
Jenscare Projects Up to RMB110 Million in First-Year Commercial Revenue on Strong Ken-Valve Uptake
Premium
Company Announcements
Jenscare Projects Up to RMB110 Million in First-Year Commercial Revenue on Strong Ken-Valve Uptake
2M ago
Jenscare Scientific Shareholders Back Sweeping Governance Changes at 2025 Extraordinary Meeting
Premium
Company Announcements
Jenscare Scientific Shareholders Back Sweeping Governance Changes at 2025 Extraordinary Meeting
3M ago
Jenscare Scientific Announces Book Closure for 2025 EGM
PremiumCompany AnnouncementsJenscare Scientific Announces Book Closure for 2025 EGM
4M ago
Jenscare Scientific’s LuX-Valve Plus Shows Promising Results in Large Annulus Patients
Premium
Company Announcements
Jenscare Scientific’s LuX-Valve Plus Shows Promising Results in Large Annulus Patients
5M ago
Jenscare Scientific Clarifies Safety Results in Recent Announcements
Premium
Company Announcements
Jenscare Scientific Clarifies Safety Results in Recent Announcements
5M ago
Jenscare Scientific Cancels Book Closure Period for EGM
PremiumCompany AnnouncementsJenscare Scientific Cancels Book Closure Period for EGM
6M ago
Jenscare Scientific Co., Ltd. Announces 2025 Extraordinary General Meeting to Consider Issuance Mandate
Premium
Company Announcements
Jenscare Scientific Co., Ltd. Announces 2025 Extraordinary General Meeting to Consider Issuance Mandate
6M ago
Jenscare Scientific Reports Interim Results and Achieves Key Milestones in Cardiac Intervention Products
Premium
Company Announcements
Jenscare Scientific Reports Interim Results and Achieves Key Milestones in Cardiac Intervention Products
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100